Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Organon Pharma Indonesia Tbk. (SCPI) vs Tempo Intimedia Tbk. (TMPO) Price & Performance

Organon Pharma Indonesia Tbk.Trade
Tempo Intimedia Tbk.Trade

Price performance (Past 24H)

Key statistics

Organon Pharma Indonesia Tbk. vs Tempo Intimedia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tempo Intimedia Tbk. trades at Rp151 (market cap 168.27B, 13.5M 24h volume). The key difference: Tempo Intimedia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

SCPITMPO
Market Cap
104.4B168.27B
Volume
13.5M
Lot
135K
Turnover
2.05B
Average Price
151.71
Value
2.05B
Indicative Equilibrium Price
151
Indicative Equilibrium Volume
1.54K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCPI
View details
TMPO
View details

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI

About Tempo Intimedia Tbk.

PT Tempo Inti Media Tbk (the Company) was established under its origin name of PT Arsa Raya Perdana on August 27, 1996 , based on deed No.77 of notary Sulaimansjah, SH. The Company’s articles of association has been amended from time to time, the latest of which was drawn up in notarial deed No.49 dated Sept 29, 2000 of Fathiah Helmi, S.H., relating to, among others, the change of company's name, the increase in authorized and issued capital of the Company in connection with the first offering, and stock split.

Read more on TMPO